BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29917299)

  • 1. Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer.
    Shinke G; Yamada D; Eguchi H; Iwagami Y; Asaoka T; Noda T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
    Cancer Sci; 2018 Aug; 109(8):2520-2531. PubMed ID: 29917299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
    Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
    Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
    Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
    Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.
    Li S; Hong H; Lv H; Wu G; Wang Z
    Med Sci Monit; 2016 May; 22():1593-600. PubMed ID: 27170223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications.
    Yang J; Ren B; Ren J; Yang G; Fang Y; Wang X; Zhou F; You L; Zhao Y
    J Exp Clin Cancer Res; 2023 Jun; 42(1):155. PubMed ID: 37370109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
    von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
    Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
    Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B
    Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.
    Chen K; Qian W; Li J; Jiang Z; Cheng L; Yan B; Cao J; Sun L; Zhou C; Lei M; Duan W; Ma J; Ma Q; Ma Z
    Mol Oncol; 2017 Oct; 11(10):1475-1492. PubMed ID: 28783244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer.
    Wang W; Gao J; Man XH; Li ZS; Gong YF
    Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Li K; Xu B; Xu G; Liu R
    Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
    Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
    Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.
    He J; Shen S; Lu W; Zhou Y; Hou Y; Zhang Y; Jiang Y; Liu H; Shao Y
    Oncotarget; 2016 May; 7(22):32754-64. PubMed ID: 27092878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.